TOIIW
The Oncology Institute IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-602.09
Beta
0.36
52W High
$0.27
52W Low
$0.03
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-7.97%
Forward P/E
—
PEG Ratio
—
About The Oncology Institute Inc
The Oncology Institute Inc. (TOIIW) is a premier provider of specialized cancer care, dedicated to delivering high-quality and accessible treatment through an extensive network of outpatient facilities. By focusing on innovative therapies and a patient-centric approach, the company aims to enhance clinical outcomes and optimize the patient experience. With the increasing demand for specialized oncology services, The Oncology Institute is strategically positioned for growth and market expansion, signaling substantial long-term value potential for institutional investors.
Fundamentals
| Revenue (TTM) | $545.76M |
| Gross Profit (TTM) | $82.50M |
| EBITDA | $-25.91M |
| Operating Margin | -4.42% |
| Return on Equity | -4132.00% |
| Return on Assets | -12.30% |
| Revenue/Share (TTM) | $5.54 |
| Book Value | $-0.16 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | 0 |
| Float | $87.41M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026